ABOS
Price
$1.43
Change
+$0.01 (+0.70%)
Updated
Aug 18, 04:59 PM (EDT)
Capitalization
86.01M
91 days until earnings call
ABP
Price
$0.27
Change
-$0.00 (-0.00%)
Updated
Aug 18, 04:59 PM (EDT)
Capitalization
16.17M
Interact to see
Advertisement

ABOS vs ABP

Header iconABOS vs ABP Comparison
Open Charts ABOS vs ABPBanner chart's image
Acumen Pharmaceuticals
Price$1.43
Change+$0.01 (+0.70%)
Volume$687
Capitalization86.01M
Abpro Holdings
Price$0.27
Change-$0.00 (-0.00%)
Volume$280
Capitalization16.17M
ABOS vs ABP Comparison Chart in %
Loading...
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ABP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABOS vs. ABP commentary
Aug 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABOS is a Hold and ABP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 19, 2025
Stock price -- (ABOS: $1.42 vs. ABP: $0.25)
Brand notoriety: ABOS and ABP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABOS: 35% vs. ABP: 1%
Market capitalization -- ABOS: $86.01M vs. ABP: $16.17M
ABOS [@Biotechnology] is valued at $86.01M. ABP’s [@Biotechnology] market capitalization is $16.17M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.71B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABOS’s FA Score shows that 0 FA rating(s) are green whileABP’s FA Score has 1 green FA rating(s).

  • ABOS’s FA Score: 0 green, 5 red.
  • ABP’s FA Score: 1 green, 4 red.
According to our system of comparison, ABP is a better buy in the long-term than ABOS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABOS’s TA Score shows that 5 TA indicator(s) are bullish while ABP’s TA Score has 5 bullish TA indicator(s).

  • ABOS’s TA Score: 5 bullish, 3 bearish.
  • ABP’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ABOS is a better buy in the short-term than ABP.

Price Growth

ABOS (@Biotechnology) experienced а +4.41% price change this week, while ABP (@Biotechnology) price change was +2.28% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.86%. For the same industry, the average monthly price growth was +22.78%, and the average quarterly price growth was +23.29%.

Reported Earning Dates

ABOS is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Biotechnology (+8.86% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABOS($86M) has a higher market cap than ABP($16.2M). ABOS YTD gains are higher at: -17.442 vs. ABP (-85.944). ABP has higher annual earnings (EBITDA): -10.08M vs. ABOS (-111.98M). ABOS has more cash in the bank: 149M vs. ABP (1.26M). ABP has less debt than ABOS: ABP (3.25M) vs ABOS (29M). ABP has higher revenues than ABOS: ABP (183K) vs ABOS (0).
ABOSABPABOS / ABP
Capitalization86M16.2M531%
EBITDA-111.98M-10.08M1,111%
Gain YTD-17.442-85.94420%
P/E RatioN/AN/A-
Revenue0183K-
Total Cash149M1.26M11,816%
Total Debt29M3.25M893%
TECHNICAL ANALYSIS
Technical Analysis
ABOSABP
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
17%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 4 days ago
57%
Momentum
ODDS (%)
Bullish Trend 4 days ago
82%
Bearish Trend 4 days ago
26%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
14%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
38%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
31%
Advances
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 8 days ago
51%
Declines
ODDS (%)
Bearish Trend 18 days ago
88%
Bearish Trend 12 days ago
74%
BollingerBands
ODDS (%)
N/A
Bearish Trend 4 days ago
18%
Aroon
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
26%
View a ticker or compare two or three
Interact to see
Advertisement
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ABP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PSTO0.03N/A
+3.72%
Powerstorm Holdings, Inc.
NESRF11.900.14
+1.19%
Northern Star Resources Ltd
NZTCF1.18N/A
N/A
Spark New Zealand Limited
AMNF9.30-0.10
-1.06%
Armanino Foods of Distinction, Inc.
GAYMF0.30-0.02
-6.80%
Galway Metals Inc.

ABOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABOS has been loosely correlated with CRBU. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ABOS jumps, then CRBU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABOS
1D Price
Change %
ABOS100%
+1.43%
CRBU - ABOS
47%
Loosely correlated
-1.00%
KYTX - ABOS
46%
Loosely correlated
-0.85%
BEAM - ABOS
45%
Loosely correlated
+1.08%
GLSI - ABOS
45%
Loosely correlated
+0.75%
FHTX - ABOS
43%
Loosely correlated
-3.21%
More

ABP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABP has been loosely correlated with XFOR. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ABP jumps, then XFOR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABP
1D Price
Change %
ABP100%
N/A
XFOR - ABP
50%
Loosely correlated
-9.24%
FBIO - ABP
31%
Poorly correlated
+8.16%
NGNE - ABP
30%
Poorly correlated
+1.53%
SVRA - ABP
26%
Poorly correlated
+1.00%
ABOS - ABP
26%
Poorly correlated
+1.43%
More